Loading data
HCTINasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 13.89 m USD | 11.7 m USD | 33.2 m USD | 45.89 m USD | 35.27 m USD |
| Cost of revenue | 12 m USD | 8.81 m USD | 26.43 m USD | 34.59 m USD | 24.75 m USD |
| Gross profit | 1.24 bn USD | 1.07 bn USD | 1.07 bn USD | — | — |
| Research and development expense | 536 k USD | 429 k USD | 799 k USD | 8.14 m USD | 5.26 m USD |
| Selling, general and administrative expense | — | — | — | 0 USD | 0 USD |
| Operating profit | -9.79 m USD | -4.75 m USD | -7.7 m USD | -16.32 m USD | -5.36 m USD |
| Interest expense | 567 k USD | — | — | 212 k USD | 567 k USD |
| Profit before tax | -9.48 m USD | -5.96 m USD | -8.65 m USD | -13.85 m USD | -5.93 m USD |
| Income tax expense | — | 12 k USD | 35 k USD | 506 k USD | 24 k USD |
| Net income (reported basis) | -9.48 m USD | -5.97 m USD | -8.69 m USD | -14.36 m USD | -5.95 m USD |
| Net income attributable to common shareholders | 9.43 m USD | 5.97 m USD | -8.69 m USD | -14.36 m USD | -5.95 m USD |
| Basic earnings per share | -152.3 USD/share | -16,909.3 USD/share | -2.08 USD/share | -3.88 USD/share | — |
| Diluted earnings per share | -152.3 USD/share | -16,909.3 USD/share | -2.08 USD/share | -3.88 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.